All of this has weighed on stock performance, leaving the shares down almost 50% over the past three years. Considering this, is it time to dump Pfizer? Let's find out. First, a quick summary of the ...

Maxell (TSE:6810) posted earnings that are forecast to grow 14.6% per year, outpacing the broader Japanese market’s 7.8% annual growth. Revenue is set to climb 4.9%, also ahead of the market’s 4.5% ...

China and Iran should strengthen "wise and balanced" cooperation to jointly counter modern challenges and shape a new world ...

Thousands of bicycles have taken over Dubai's busiest highway as part of an annual ride for the city's fitness challenge ...

He said the armed forces face the same challenges "whether at the borders, through terrorism, natural disasters, cyber warfare, or the new frontiers like space warfare involving satellites, and ...